This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit July 23, 2014

Home   About   Join Us   Annual Conference   The Voice   Career Center   Resources   Education Plus  

 

Cervical cancer prevention program saves lives
CFAH
A 23-year old federal program for the early detection and treatment of cervical cancer markedly reduces illness and death among underserved, low-income women, yet its impact has been reduced by the fact that it has reached only 10 percent of the eligible population, finds a new study in the American Journal of Preventive Medicine.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


ASCT 2014-2015 Educational Webinar Series
ASCT
The ASCT 2014-2015 Educational Webinar Series begins in September 2014. View the full webinar schedule here, and download the registration forms using the links below.

Register (2014 form)
Register (2015 form)

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


UPCOMING EVENTS

Date Event Location More information
Sept. 18 Skills and Tools Required to be a Good Laboratory Manager Your PC
Anil R. Prasad, M.D., Associate Professor, Department of Pathology at the University of Arizona Health Science Center in Tucson, Arizona.
More info | Register

Available for 6 months after subscribing

Quality Assessment Center (QAC) Document Control for Cytopathology Workbench

Your PC

Details

Available for 6 months after subscribing

Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench

Your PC

Details


INDUSTRY NEWS


Genticel HPV vaccine study on track
Drug Discovery & Development
Genticel, a French biotechnology company and leading developer of therapeutic vaccines, announce that the enrollment of the Phase 2 RHEIA-VAC study has reached the halfway mark of its recruitment target. The study is on track with Genticel’s initial projections. All of the 39 investigation sites across seven European countries (Belgium, Finland, France, Germany, the Netherlands, Spain and the U.K.) are fully operational.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Cervical cancer vaccine might not boost clot risk
HealthDay via WebMD
Concerns that the human papillomavirus vaccine may increase the risk of serious blood clots seem unfounded, a new study says. The study of half a million Danish women who received the HPV vaccine, which protects against cervical cancer and other health problems, found no link between the shots and the formation of blood clots known as venous thromboembolisms. In the United States it's called the Gardasil vaccine. Concerns about such a link had been raised in previous research.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Roche wins priority review for Avastin in cervical cancer
Reuters
Swiss drugmaker Roche said U.S. health regulators have granted a priority review of its Avastin drug when combined with chemotherapy to treat women with cervical cancer. An approval by the U.S. Food and Drug Administration for treating advanced cervical cancer would open another large market for the medicine in patients for whom chemotherapy has been largely ineffective. About 4,000 women in the United States and 250,000 worldwide die each year from the disease.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MORE NEWS


CDC admits lapses in lab safety, promises reforms
MedPage Today
A CDC investigation confirmed that multiple failures in laboratory safety had caused possible exposures of lab personnel to anthrax and dangerous influenza strains, and officials promised sweeping reforms. In a report, the agency said that, in the case of the accidental anthrax exposure in June, lab workers were guilty of "failure to follow an approved, written study plan that met all laboratory safety requirements."
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword LAB


Breast cancer: Advancements in surgery
Rosemary Sparacio
Breast cancer is the second-leading cause of death among women, with more than 40,000 deaths in the United States each year. As in the areas of breast cancer diagnosis and treatment, research and development advances in surgery are also being seen. These advances not only improve the actual surgery techniques, but also the methods and processes prior to and following surgery. Here is a closer look at some of the latest research.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


HPV vaccine for oral cancer?
JAMA
The vaccine that protects teenage girls and young women against cervical cancer also may help prevent many oropharyngeal cancers in the United States. A recent analysis showed that 72 percent of 557 invasive oropharyngeal squamous cell carcinoma samples tested positive for human papillomavirus. In nearly two-thirds of those samples, investigators detected HPV-16 and HPV-18, the strains most often linked with cervical cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 

ASCT Viewpoint
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Esther Cho, Content Editor, 469.420.2671   
Contribute news

This edition of ASCT Viewpoint was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
July 9, 2014
June 25, 2014
June 11, 2014
May 28, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063